Patrycja Kłaput

Patrycja Kłaput is an experienced professional in pharmacovigilance and project management, currently serving as the Pharmacovigilance Director at PrimeVigilance Ltd. since November 2021, focusing on the Vaccine Business Unit. Prior to this, Patrycja held several leadership roles at TFS - Clinical Contract Research Organization from May 2018 to November 2021, where responsibilities included overseeing the pharmacovigilance system, managing project managers, and leading aggregate reporting and risk management teams. Patrycja's earlier experience includes significant roles at GSK, Rapofarm, and Sanofi-Aventis, with a strong foundation in drug safety, regulatory compliance, and team training. Patrycja holds postgraduate and master's degrees in Medical Pharmacy and Chemical Biotechnology, respectively.